Semiconductor machinery manufacturer Applied Materials (NASDAQ:AMAT) in Q1 CY2025, with sales up 6.8% year on year to $7.1 ...

Q2 2025 Earnings Call Transcript May 15, 2025 Applied Materials, Inc. beats earnings expectations. Reported EPS is $2.39, ...

What Happened? Shares of semiconductor machinery manufacturer Applied Materials (NASDAQ:AMAT) fell 6% in the afternoon ...

Semiconductor equipment manufacturer Applied Materials reported second-quarter results that were mixed relative to analyst expectations. Revenue rose by 7% year over year, a bit short of the ...

Applied Materials AMAT is scheduled to report second-quarter fiscal 2025 results on May 15. For the fiscal second quarter, AMAT expects revenues to be $7.1 billion (+/- $400 million). The Zacks ...

Applied Materials (AMAT) came out with quarterly earnings of $2.39 per share, beating the Zacks Consensus Estimate of $2.31 per share. This compares to earnings of $2.09 per share a year ago.

For the quarter ended April 2025, Applied Materials (AMAT) reported revenue of $7.1 billion, up 6.8% over the same period last year. EPS came in at $2.39, compared to $2.09 in the year-ago quarter.

The most recent trading session ended with Applied Materials (AMAT ... At the same time, the Dow lost 0.24%, and the tech-heavy Nasdaq lost 0.74%. Heading into today, shares of the maker of ...

Applied Materials is a major manufacturer of semiconductor fabrication equipment, covering deposition, etching and inspection, serving the most crucial stages of chip manufacturing. Applied ...

Below is Validea's guru fundamental report for APPLIED MATERIALS INC (AMAT). Of the 22 guru strategies we follow, AMAT rates highest using our Patient Investor model based on the published ...

In trading on Wednesday, shares of Applied Materials, Inc. (Symbol: AMAT) crossed above their 200 day moving average of $175.15, changing hands as high as $175.28 per share. Applied Materials ...

Below is Validea's guru fundamental report for APPLIED MATERIALS INC (AMAT). Of the 22 guru strategies we follow, AMAT rates highest using our Patient Investor model based on the published ...